NVAX vs TWLO · P/E 2.5, rev $196.2M vs P/E 1087, rev $2.91B
Novavax Inc (NVAX) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Novavax Inc (NVAX) is a biotechnology company listed on US.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported NVAX revenue for 2026-06-30 was $196.2M. Net income was -$62.9M. Revenue was up 40.6% from 2026-03-31 to 2026-06-30. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Latest reported TWLO revenue for 2026-06-30 was $2.91B. Net income was $1.16B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
NVAX currently screens at market cap $1.09B and trailing P/E 2.5. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the NVAX and TWLO stock pages for the full models.
Not investment advice.